KYN 54: structure given in first source; a novel synthesized retinoid; potential chemopreventive agent for intestinal neoplasm
ID Source | ID |
---|---|
PubMed CID | 6439189 |
SCHEMBL ID | 7518444 |
MeSH ID | M0207502 |
Synonym |
---|
91269-98-6 |
ea2a4gnx48 , |
unii-ea2a4gnx48 |
ccris 7131 |
kyn 54 |
2(5h)-furanone, 5-hydroxy-4-(2-phenylethenyl)-, (e)- |
(e)-5-hydroxy-4-(2-phenylethenyl)-2(5h)-furanone |
SCHEMBL7518444 |
kyk-54 |
2(5h)-furanone, 5-hydroxy-4-((1e)-2-phenylethenyl)- |
kyn-54 |
kyk 54 |
5-hydroxy-4-(2-phenyl-(e)-ethenyl)-2(5h)furanone |
Q27277062 |
Excerpt | Relevance | Reference |
---|---|---|
" These rats were fed diet containing 100 or 200 ppm KYN-54 for 5 weeks, starting 1 week before the first dosing of AOM." | ( Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats. Hara, A; Hirose, Y; Kawamori, T; Mori, H; Satoh, K; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J, 1995) | 0.29 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |